204 related articles for article (PubMed ID: 19434413)
1. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Orhan Z; Cevher E; Yildiz A; Ahiskali R; Sensoy D; Mülazimoğlu L
Arch Orthop Trauma Surg; 2010 Jan; 130(1):135-42. PubMed ID: 19434413
[TBL] [Abstract][Full Text] [Related]
2. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
[TBL] [Abstract][Full Text] [Related]
3. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.
Jia WT; Luo SH; Zhang CQ; Wang JQ
Antimicrob Agents Chemother; 2010 Jan; 54(1):170-6. PubMed ID: 19917757
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
Jia WT; Fu Q; Huang WH; Zhang CQ; Rahaman MN
Antimicrob Agents Chemother; 2015 Dec; 59(12):7571-80. PubMed ID: 26416858
[TBL] [Abstract][Full Text] [Related]
7. In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects.
Yenice I; Caliş S; Atilla B; Kaş HS; Ozalp M; Ekizoğlu M; Bilgili H; Hincal AA
J Microencapsul; 2003; 20(6):705-17. PubMed ID: 14594660
[TBL] [Abstract][Full Text] [Related]
8. Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study.
Wang F; Ni B; Zhu Z; Liu F; Zhu YZ; Liu J
Arch Orthop Trauma Surg; 2011 Jan; 131(1):111-9. PubMed ID: 20661743
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J
Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152
[TBL] [Abstract][Full Text] [Related]
10. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model.
Zhang X; Jia W; Gu Y; Xiao W; Liu X; Wang D; Zhang C; Huang W; Rahaman MN; Day DE; Zhou N
Biomaterials; 2010 Aug; 31(22):5865-74. PubMed ID: 20434766
[TBL] [Abstract][Full Text] [Related]
11. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
Mistry S; Roy S; Maitra NJ; Kundu B; Chanda A; Datta S; Joy M
J Control Release; 2016 Oct; 239():169-81. PubMed ID: 27582374
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis.
Silva V; Miranda C; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P
Int J Antimicrob Agents; 2020 Jul; 56(1):106021. PubMed ID: 32439480
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model.
Kandemir O; Oztuna V; Colak M; Akdag A; Camdeviren H
J Chemother; 2008 Feb; 20(1):53-7. PubMed ID: 18343744
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.
Ueng SW; Lin SS; Wang IC; Yang CY; Cheng RC; Liu SJ; Chan EC; Lai CF; Yuan LJ; Chan SC
J Orthop Surg Res; 2016 Apr; 11(1):52. PubMed ID: 27121956
[TBL] [Abstract][Full Text] [Related]
15. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis.
Lazarettos J; Efstathopoulos N; Papagelopoulos PJ; Savvidou OD; Kanellakopoulou K; Giamarellou H; Giamarellos-Bourboulis EJ; Nikolaou V; Kapranou A; Papalois A; Papachristou G
Clin Orthop Relat Res; 2004 Jun; (423):253-8. PubMed ID: 15232458
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal shockwave increases the effectiveness of systemic antibiotic treatment in implant-related chronic osteomyelitis: experimental study in a rat model.
Inanmaz ME; Uslu M; Isik C; Kaya E; Tas T; Bayram R
J Orthop Res; 2014 Jun; 32(6):752-6. PubMed ID: 24676969
[TBL] [Abstract][Full Text] [Related]
17. Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.
Ersoz G; Oztuna V; Coskun B; Eskandari MM; Bayarslan C; Kaya A
J Chemother; 2004 Feb; 16(1):51-5. PubMed ID: 15077999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
[TBL] [Abstract][Full Text] [Related]
19. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
20. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation.
El-Kamel AH; Baddour MM
Drug Deliv; 2007 Aug; 14(6):349-56. PubMed ID: 17701524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
